Radius Health is a Boston-based, commercial biopharmaceutical company currently focused on bone health, oncology and neuroscience spaces.
Location: United States, Massachusetts, Boston
Investors 3
| Date | Name | Website |
| 27.03.2023 | Webster Eq... | websterequ... |
| 30.08.2023 | OrbiMed | orbimed.co... |
| 21.08.2022 | Gurnet Poi... | gurnetpoin... |
Mentions in press and media 13
| Date | Title | Description |
| 08.11.2021 | Radius Health, Inc.: Third Quarter 2021 Results - Form 8-K | Radius Health, Inc.: Third Quarter 2021 Results • TYMLOS® Q3, 2021 net revenue: $57 million, +13% vs. Q3, 2020 • Added 4,461 new patients on TYMLOS in Q3, 2021, +10% vs. Q3, 2020 • Adjusted EBITDA of ($11) million vs. $9 million in Q3, 2020... |
| 08.11.2021 | Radius Health, Inc.: Third Quarter 2021 Results | TYMLOS® Q3, 2021 net revenue: $57 million, +13% vs. Q3, 2020 Added 4,461 new patients on TYMLOS in Q3, 2021, +10% vs. Q3, 2020 Adjusted EBITDA of ($11) million vs. $9 million in Q3, 2020 which included elacestrant license revenue ATOM Pivot... |
| 25.09.2020 | Radius Health & Menarini Group Provide Elacestrant Update USA - English España - español USA - English Latin America - español France - Français | |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| 29.04.2013 | Radius Health Completes $43M Equity Financing | Radius Health, Inc., a Cambridge, MA-based biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women’s health conditions, completed a $43m equity financing. The round was led by F2 Bi... |
| 16.12.2011 | Radius Health Closes $21.4M Tranch | CAMBRIDGE, MA, Radius Health, announced the closing of the third and final equity tranche of the company's $91 million financing round announced in May 2011. The third tranche included $21.4 million in equity financing from Radius' curren... |
| 24.11.2011 | Radius Health Closes Second Tranche of $91m Financing Round | Radius Health, a Cambridge, Massachusetts-based developer of a new generation of drug therapies for osteoporosis and women’s health, closed the second of its three-tranche $91m financing round announced in May 2011 (read here) . This $27.65... |
| 25.05.2011 | Radius Health Raises $91M in Third Financing Round | Radius Health, Inc., a Cambridge, Massachusetts-based developer of drug therapies for osteoporosis and women’s health, has raised approximately $91m in its third financing round. It includes: – $66m in equity financing from new investors BB... |
| 23.05.2008 | Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech | Share Share on Facebook Share on Twitter LinkedIn Email Reprints It’s official: 2007 rocked for New England biotech. Whether you look at IPOs, mergers, or venture activity, the region is consistently among the nation’s leaders. And on a per... |
| 17.04.2008 | Radius Health is Betting on a Better Treatment for Osteoporosis | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Radius Health, a biotech company in Cambridge, MA, has a lot hanging on its clinical trial of a new treatment for osteoporosis. Two weeks ago all the patients were enrolled in... |
Show more